| 000 | 01572 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517232605.0 | ||
| 264 | 0 | _c20190510 | |
| 008 | 201905s 0 0 eng d | ||
| 022 | _a1545-5017 | ||
| 024 | 7 |
_a10.1002/pbc.27401 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGopakumar, Kaduveettil Gopinathan | |
| 245 | 0 | 0 |
_aRisk-based management strategy and outcomes of tumor lysis syndrome in children with leukemia/lymphoma: Analysis from a resource-limited setting. _h[electronic resource] |
| 260 |
_bPediatric blood & cancer _c12 2018 |
||
| 300 |
_ae27401 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aBurkitt Lymphoma _xcomplications |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aDeveloping Countries |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGout Suppressants _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndia _xepidemiology |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 |
_aLeukemia _xcomplications |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPoverty |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aTumor Lysis Syndrome _xdrug therapy |
| 650 | 0 | 4 |
_aUrate Oxidase _xtherapeutic use |
| 700 | 1 | _aSeetharam, Shwetha | |
| 700 | 1 | _aKm, Jagathnath Krishna | |
| 700 | 1 | _aNair, Manjusha | |
| 700 | 1 | _aRajeswari, Binitha | |
| 700 | 1 | _aCs, Guruprasad | |
| 700 | 1 | _aVr, Prasanth | |
| 700 | 1 | _aThankamony, Priyakumari | |
| 773 | 0 |
_tPediatric blood & cancer _gvol. 65 _gno. 12 _gp. e27401 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/pbc.27401 _zAvailable from publisher's website |
| 999 |
_c28723763 _d28723763 |
||